Bosnia and Herzegovina vs Canada: Previously treated cases tested for RR-/MDR-TB
Bosnia and Herzegovina
89.0%
in 2024
Canada
88.0%
in 2024
Bosnia and Herzegovina rank
87th
Canada rank
90th
Previously treated cases tested for RR-/MDR-TB over time
- Bosnia and Herzegovina
- Canada
How they compare
Bosnia and Herzegovina currently reports 89.0% against 88.0% in Canada, a difference of 1.0%.
The two have swapped places 3 times across 15 shared years of data; in 2006 it was Canada ahead.
Bosnia and Herzegovina ranks 87th and Canada ranks 90th of 180 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 2 and Canada in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.2% | 77.8% | 3.5% | Bosnia and Herzegovina |
| 2010s | 57.4% | 76.3% | 18.9% | Canada |
| 2020s | 92.5% | 78.8% | 13.8% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bosnia and Herzegovina or Canada?
- Bosnia and Herzegovina, at 89.0% against 88.0% in Canada as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bosnia and Herzegovina and Canada?
- 1.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Canada?
- 15 years are reported by both, from 2006 to 2024.
- How do Bosnia and Herzegovina and Canada rank globally for previously treated cases tested for rr-/mdr-tb?
- Bosnia and Herzegovina ranks 87th and Canada ranks 90th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.